Newly Diagnosed Acute Myeloid Leukemia (AML)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB12874 | Quizartinib | A FLT3 inhibitor used in combination with cytarabine and anthracycline to treat acute myeloid leukemia with FLT3 internal tandem duplication |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00987 | Cytarabine | 1 | Active Not Recruiting | 1 |
| DB00694 | Daunorubicin | 1 | Active Not Recruiting | 1 |
| DB13874 | Enasidenib | 1 | Active Not Recruiting | 1 |
| DB00773 | Etoposide | 1 | Active Not Recruiting | 1 |
| DB01177 | Idarubicin | 1 | Active Not Recruiting | 1 |
| DB14568 | Ivosidenib | 1 | Active Not Recruiting | 1 |
| DB01204 | Mitoxantrone | 1 | Active Not Recruiting | 1 |
| DB00928 | Azacitidine | 3 | Active Not Recruiting | 1 |
| DB14568 | Ivosidenib | 3 | Active Not Recruiting | 1 |